Trials / Completed
CompletedNCT01069783
Study of A3309 in Patients With Dyslipidemia
A Phase IIa, Double-blind, Randomised, Placebo-controlled, Dose-finding Efficacy and Safety Study of A3309 in Patients With Dyslipidemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Albireo · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with dyslipidemia (high cholesterol levels).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A3309 | A3309 in two different dosage levels |
| DRUG | A3309 | A3309 in two different dosage levels for the duration of the study |
| DRUG | Placebo | Placebo comparator once daily for the duration of the trial |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-02-17
- Last updated
- 2024-03-07
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01069783. Inclusion in this directory is not an endorsement.